Counterfeit bulk drugs: hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000, Volume 4
U.S. G.P.O., 2000 - Medical - 423 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adverse events Agency Agency's agents approved authentic Baker Bliley bulk pharmaceutical Burr CDER certificates of analysis Chairman China Commissioner Committee companies compliance concern counterfeit bulk drugs counterfeit drugs counterfeit pharmaceutical Criminal Investigations Cytotec database detect developed Dingell documents domestic Drug Administration drug imports drug listing drug products enforcement entry Evaluation FDA's finished drug Flavine Flavine International Food and Drug foreign drug manufacturers foreign inspections foreign manufacturers Forensic Chemistry Fred Upton gentamicin sulfate Henney human drug identified import alert import inspectors imported counterfeit industry issue labeling letter Long March manufacturing practices medicines mifepristone misoprostol OASIS operations pharmaceutical products pharmacies potential prescription drugs problem prosecution record regulatory reimportation reports requirements safety samples shipments shipped specific Strickland Stupak substandard surveillance testing U.S. agent U.S. Customs Service United